NUTXNasdaqServices-Business Services, NECFiscal year ends December 31
Nutex Health Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$191.25+5.15 (+2.77%)
Close on Oct 19, 2026
- Market cap
- $1.34B
- P/E (TTM)
- 7.5
- Dividend yield
- –
Nutex Health Inc. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Hospital division revenue | $844.16M | $449.06M | $218.07M | $198.51M | $331.53M | $274.03M | 96.4% | +88.0% |
| Population health management division revenue | $31.10M | $30.89M | $29.58M | $20.79M | – | – | 3.6% | +0.7% |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Hospital division revenue | $844.16M | $449.06M | $218.07M | $198.51M | $331.53M | $274.03M | 96.4% | +88.0% |
| Population health management division revenue | $31.10M | $30.89M | $29.58M | $20.79M | – | – | 3.6% | +0.7% |
By region
From the segment and revenue-disaggregation notes of Nutex Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.